Get startedLog in
    Picture of Biosenic SA logo

    BIOS — Biosenic SA News Story

    0.000.00%
    be flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapValue Trap
    All News

    Brief: BioSenic Start Of SLE, SSC Phase 2 Clinical Trials Not Envisioned Before 2025

    Picture of Biosenic SA logoBiosenic SA
    25/10/2023 06:20
    Oct 25 (Reuters) - Bone Therapeutics SA  BIOS.BR :
    * IN 2024 BIOSENIC EXPECTS TO USE PROCEEDS OF ANTICIPATED
FUTURE
FUNDRAISINGS IN PRIORITY FOR PROGRESSING PHASE 3 CLINICAL TRIAL
IN CGVHD
    * START OF SLE AND SSC PHASE 2 CLINICAL TRIALS IS THEREFORE
NOT
ENVISIONED BEFORE 2025

Source text for Eikon:  ID:nGNE2MQHSY 
Further company coverage:  BIOS.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Biosenic SA

    See all news